Please login to the form below

Not currently logged in

GSK to acquire stake in Aspen

GSK is to take a 16 per cent stake in Aspen Pharmacare Holdings - Africa's biggest generic drug maker

GlaxoSmithKline (GSK) is to take a 16 per cent stake in Aspen Pharmacare Holdings - Africa's biggest generic drug maker. The deal, based on transfer of assets and subject to regulatory approvals, is said to be worth 3.47bn rand ($418m).

Aspen acquires the rights for its subsidiary company, Pharmacare, to distribute GSK products in South Africa and will collaborate with GSK on marketing and selling prescription products in sub-Saharan Africa (except South Africa, Lesotho and Swaziland). A newly formed subsidiary will acquire GSK's manufacturing facility in Bad Oldesloe, Germany. Aspen Global will acquire eight products for worldwide distribution: the chemotherapy drugs Leukeran, Purinethol and Alkeran (excluding US); Kemadrin – for Parkinson's disease; Lanvis and Myleran – for leukaemia; Septrin – a broad-spectrum antimicrobial; and Trandate – for hypertension.

GSK and Aspen have collaborated on a number of projects in recent years. Among other ventures, Aspen distributes some of GSK's prescription products in South Africa, was licensed to manufacture antiretrovirals before patent expiry and distributes GSK's OTC products in Australia.

12th May 2009


Featured jobs

Subscribe to our email news alerts


Add my company

StratX creates experiential learning programs instilled with emotion and competitive spirit, leading to lasting on-the-job change. Our memorable approach develops...

Latest intelligence

It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...
Emma Walmsley 2
30 Women Leaders in UK Healthcare (part 3)
Continuing our special feature on Women Leaders in UK Healthcare...
Louise Houson
30 Women Leaders in UK Healthcare
The enormous challenges facing UK healthcare mean it needs great leaders. PME’s Group Editor Andrew McConaghie introduces 30 outstanding innovators and trailblazers helping to shape the future...